Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Nutrients ; 11(4)2019 Apr 17.
Artículo en Inglés | MEDLINE | ID: mdl-30999554

RESUMEN

Although several kinds of amino acids (AAs) are known to affect physiological actions during exercise, little is known about the combined effects of a mixture of several AAs on fatigue during exercise. The aim of the present study was to investigate the effect of an AA mixture supplement containing arginine, valine, and serine on exercise-induced fatigue in healthy volunteers. These AAs were selected because they were expected to reduce fatigue during exercise by acting the positive effects synergistically. A randomized, double-blinded, placebo-controlled crossover trial was conducted. Thirty-nine males ingested an AA mixture containing 3600 mg of arginine, 2200 mg of valine, and 200 mg of serine or a placebo each day for 14 days. On the 14th day, the participants completed an exercise trial on a cycle ergometer at 50% of VO2max for 120 min. After the two-week washout period, the participants repeated the same trial with the other test sample. The participant's feeling of fatigue based on a visual analog scale (VAS) and a rating of perceived exertion (RPE), as well as blood and physical parameters were evaluated. The feeling of fatigue based on VAS and RPE were significantly improved in AA compared to those in placebo. In the blood analysis, the increase in serum total ketone bodies during exercise and plasma tryptophan/branched-chain amino acids were significantly lower in AA than those in placebo. The present study demonstrated that supplementation with an AA mixture containing arginine, valine, and serine reduced the feeling of fatigue during exercise. The AA mixture also changed several blood parameters, which may contribute to the anti-fatigue effect.


Asunto(s)
Arginina/administración & dosificación , Ejercicio Físico/fisiología , Fatiga/prevención & control , Serina/administración & dosificación , Valina/administración & dosificación , Adulto , Arginina/farmacología , Estudios Cruzados , Método Doble Ciego , Combinación de Medicamentos , Sinergismo Farmacológico , Fatiga/etiología , Voluntarios Sanos , Humanos , Masculino , Persona de Mediana Edad , Serina/farmacología , Valina/farmacología
2.
Nutrients ; 10(5)2018 May 08.
Artículo en Inglés | MEDLINE | ID: mdl-29738462

RESUMEN

A previous in vivo study with rats suggested that a special milk protein drink manufactured using an acidification procedure to suppress the aggregation of milk proteins was absorbed quickly after feeding. We performed a randomized, double-blind, placebo-controlled, repeated-measure crossover study to investigate the short-term effects on cognitive performance in 29 healthy young adult men after they consumed this drink in the morning. After an overnight fast, subjects were tested for performance in the Uchida⁻Kraepelin serial arithmetic test and the Stroop test as well as for subjective feeling, body temperature, and heart rate variability before and after consumption of either the acidified milk protein drink or an isoenergetic placebo drink. Subjects showed a significant improvement in performance in the Uchida⁻Kraepelin test, the primary outcome measured, when they consumed the acidified milk protein drink compared with the placebo control condition. In addition, consumption of the acidified milk protein drink, compared with the placebo control, was associated with increases in vagally-mediated heart rate variability indices which, from recent theoretical perspectives, may reflect a higher ability to modulate cognitive and behavioral processes. There was no significant difference in subjective feelings and body temperature between the test drink conditions. These data suggest that consumption of the acidified milk protein drink may improve cognitive performance, with possible involvement of physiological systems that regulate cognition and behavior.


Asunto(s)
Cognición/efectos de los fármacos , Proteínas de la Leche/administración & dosificación , Adolescente , Adulto , Bebidas/análisis , Temperatura Corporal , Citratos/administración & dosificación , Ácido Cítrico/administración & dosificación , Estudios Cruzados , Método Doble Ciego , Electrocardiografía , Frecuencia Cardíaca/efectos de los fármacos , Humanos , Malatos/administración & dosificación , Masculino , Cooperación del Paciente , Citrato de Sodio , Test de Stroop , Encuestas y Cuestionarios , Resultado del Tratamiento , Vitamina B 6/administración & dosificación , Adulto Joven
4.
BMC Musculoskelet Disord ; 18(1): 385, 2017 Sep 05.
Artículo en Inglés | MEDLINE | ID: mdl-28870199

RESUMEN

BACKGROUND: The major types of commercially available gelatin hydrolysates are prepared from mammals or fish. Dietary gelatin hydrolysates from mammals were reported to improve bone mineral density (BMD) in some animal models. In contrast, there is limited study showing the effects of dietary gelatin hydrolysates from fish on BMD. The quantity and structure of peptides in the plasma after oral administration of gelatin hydrolysates depend on the gelatin source, which suggests that the biological activity of gelatin hydrolysates depend on the gelatin source. This study examined the effects of fish-derived gelatin hydrolysate (FGH) or porcine-derived gelatin hydrolysate (PGH) intake on BMD and intrinsic biomechanical properties in magnesium (Mg)-deficient rats as a model showing the decrease in both BMD and intrinsic biomechanical properties. METHODS: Four-week-old male Wistar rats were assigned into four groups: a normal group was fed a normal diet (48 mg Mg/100 g diet), a Mg-deficient (MgD) group was fed a MgD diet (7 mg Mg/100 g diet), a FGH group was fed a MgD + FGH diet (5% FGH), and a PGH group was fed a MgD + PGH diet (5% PGH) for 8 weeks. At the end of the study, BMD and intrinsic biomechanical properties of the femur were measured. RESULTS: The MgD group showed significantly lower Young's modulus, an intrinsic biomechanical property, and trabecular BMD of the femur than the normal group; however, the MgD diet did not affect cortical BMD and cortical thickness. Both the FGH and the PGH groups showed significantly higher cortical thickness and ultimate displacement of the femur than the normal group, but neither type of gelatin hydrolysate affected Young's modulus. Furthermore, the FGH group, but not the PGH group, showed significantly higher trabecular BMD than the MgD group. CONCLUSIONS: This study indicates that FGH and PGH increase cortical thickness but only FGH prevents the decrease in trabecular BMD seen in Mg-deficient rats, while neither type of gelatin hydrolysate affect intrinsic biomechanical properties.


Asunto(s)
Densidad Ósea/fisiología , Proteínas en la Dieta/administración & dosificación , Gelatina/administración & dosificación , Deficiencia de Magnesio/diagnóstico por imagen , Deficiencia de Magnesio/dietoterapia , Hidrolisados de Proteína/administración & dosificación , Animales , Magnesio/sangre , Deficiencia de Magnesio/sangre , Masculino , Ratas , Ratas Wistar , Resultado del Tratamiento
5.
Biosci Biotechnol Biochem ; 80(8): 1587-93, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-27055721

RESUMEN

We evaluated the effect of whey protein hydrolysates (WPH) on the water absorption rate in the small intestine using a rat small intestine perfusion model. The rate was significantly higher with 5 g/L WPH than with 5 g/L soy protein hydrolysates or physiological saline (p < 0.05). WPH dose-dependently increased the water absorption rate in the range of 1.25-10.0 g/L. WPH showed a significantly higher rate than an amino acid mixture whose composition was equal to that of WPH (p < 0.05). The addition of 4-aminomethylbenzoic acid, an inhibitor of PepT1, significantly suppressed WPH's enhancement of water absorption (p < 0.05). The rate of water absorption was significantly correlated with that of peptides/amino acids absorption in WPH (r = 0.82, p < 0.01). These data suggest that WPH have a high water absorption-promoting effect, to which PepT1 contributes.


Asunto(s)
Aminoácidos/farmacología , Absorción Intestinal/efectos de los fármacos , Intestino Delgado/efectos de los fármacos , Hidrolisados de Proteína/farmacología , Agua/metabolismo , Proteína de Suero de Leche/química , Animales , Transporte Biológico , Colorantes/metabolismo , Expresión Génica , Intestino Delgado/metabolismo , Cinética , Masculino , Transportador de Péptidos 1 , Perfusión , Fenolsulfonftaleína/metabolismo , Ratas , Ratas Sprague-Dawley , Simportadores/antagonistas & inhibidores , Simportadores/genética , Simportadores/metabolismo , para-Aminobenzoatos/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA